Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 13/20 | 0.70 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.53 |
| ▸ | RXRA | P19793 | 2/20 | 0.47 |
| ▸ | RARG | P13631 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8308970 | 1.00 | PPARG (0.70) | PPARGFFAR1RXRARARGCYP3A4 | |
| SCHEMBL8304045 | 0.90 | FFAR1 (0.59) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8304047 | 0.90 | FFAR1 (0.59) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8305936 | 0.88 | FFAR1 (0.62) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8305933 | 0.88 | FFAR1 (0.62) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8310743 | 0.86 | PPARG (0.56) | PPARGFFAR1RXRARARGCYP3A4 | |
| SCHEMBL8310741 | 0.86 | PPARG (0.56) | PPARGFFAR1RXRARARGCYP3A4 | |
| SCHEMBL8386374 | 0.85 | FFAR1 (0.64) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8386375 | 0.85 | FFAR1 (0.64) | PPARGFFAR1RXRARARGPPARA | |
| SCHEMBL8305197 | 0.84 | PPARG (0.51) | PPARGFFAR1RXRARARGCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5972959-A | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY, LIMITED (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0708098-B1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO CO (JP) | 1999-03-03 | — | — | EP | disclosed |
| EP-0708098-A1 | Oxime derivatives, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |